U.S. agency warns company marketing ‘stem cells’ for autism
Two agency letters put California-based Liveyon on warning and alert the public to the risks associated with stem-cell based therapies for autism.
Two agency letters put California-based Liveyon on warning and alert the public to the risks associated with stem-cell based therapies for autism.
Parents of autistic children are paying tens of thousands of dollars for stem cell therapies that often use medical waste. Despite the risks, regulators have been slow to act.
Increasing numbers of young adults with autism are pursuing a college education. Many campuses are not ready for them.
Hurricane Maria pummeled Cayo Santiago, home to more than 1,500 rhesus macaques, including some used for autism research.
Scores of parents abandon mainstream autism treatments to pursue Son-Rise, an intense, expensive — and unproven — behavioral therapy.
On Cayo Santiago island, scientists track the alliances and power struggles of a colony of feral monkeys — collecting data to generate new insights into the social challenges that people with autism face.